|4Jun 14, 6:15 PM ET

Martell Bridget A 4

4 · POINT Biopharma Global Inc. · Filed Jun 14, 2023

Insider Transaction Report

Form 4
Period: 2023-06-13
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-13+80,50380,503 total
    Exercise: $10.08Exp: 2029-06-13Common Stock (80,503 underlying)
Footnotes (1)
  • [F1]The option will vest 100% on the first anniversary of the grant date.

Documents

1 file
  • 4
    tm2318760-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT